| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |